Trial Profile
Modulation of the excitability of the occipital cerebral cortex using topiramate
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Migraine
- Focus Pharmacodynamics
- 30 Oct 2006 New trial record.